RTW Biotech Opportunities Ltd — Investor Relations & Filings
Filings indexed
545
across all filing types
Latest filing
2025-11-14
Fund Information / Fact…
Country
GG
Guernsey
Listing
IL
RTW
RTW Biotech Opportunities Ltd is an investment fund that focuses on identifying and investing in transformative assets with high growth potential across the global life sciences sector. The company's portfolio is primarily composed of biotechnology and medical technology companies. Managed by RTW Investments, LP, a specialized life sciences investment firm, the fund leverages deep scientific expertise to support companies throughout their entire lifecycle, from early-stage private ventures to publicly traded entities. The investment strategy aims to provide capital and strategic support to advance the development of innovative therapies and technologies.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Monthly Valuation Update and Factsheet | 2025-11-14 | English | |
| Evommune announces $150 million IPO | 2025-11-07 | English | |
| Holding(s) in Company | 2025-11-05 | English | |
| Total Voting Rights | 2025-11-03 | English | |
| Royalty Funding Agreement with Savara Inc. | 2025-10-31 | English | |
| Transaction in Own Shares | 2025-10-29 | English |
Browse filings by year
8 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 8319068 | Monthly Valuation Update and Factsheet | 2025-11-14 | English | ||
| 8129310 | Evommune announces $150 million IPO | 2025-11-07 | English | ||
| 8106451 | Holding(s) in Company | 2025-11-05 | English | ||
| 8067317 | Total Voting Rights | 2025-11-03 | English | ||
| 8062728 | Royalty Funding Agreement with Savara Inc. | 2025-10-31 | English | ||
| 8055202 | Transaction in Own Shares | 2025-10-29 | English | ||
| 11397822 | Novartis to acquire Avidity Biosciences | 2025-10-27 | English | ||
| 8030855 | Capital Allocation Plan based on M&A successes | 2025-10-20 | English | ||
| 8024691 | Kailera Therapeutics announces Series B financing | 2025-10-15 | English | ||
| 8017472 | Monthly Valuation Update and Factsheet | 2025-10-14 | English | ||
| 7982740 | Novo Nordisk to acquire Akero Therapeutics | 2025-10-10 | English | ||
| 7943579 | Total Voting Rights | 2025-10-01 | English | ||
| 7939439 | Transaction in Own Shares | 2025-09-30 | English | ||
| 11392219 | Genmab to acquire Merus | 2025-09-30 | English | ||
| 7936612 | Transaction in Own Shares | 2025-09-29 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Activities of non-money market investments funds
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
029 Group SE
Global investment platform for the hospitality and lifestyl…
|
Z29 | DE | Financial and insurance activit… |
|
21Shares Bitcoin ETP
An ETP providing direct, physically backed exposure to Bitc…
|
ABTC | CH | Financial and insurance activit… |
|
21Shares Ethereum ETF
An ETF holding spot ether to track its performance, with po…
|
TETH | US | Financial and insurance activit… |
|
2invest AG
An investment company focusing on biotech, life science, an…
|
2INV | DE | Financial and insurance activit… |
|
3i Group PLC
An international investment company focused on Private Equi…
|
III | GB | Financial and insurance activit… |
|
3i Infrastructure PLC
Manages mid-market infrastructure assets in developed marke…
|
3IN | JE | Financial and insurance activit… |
|
450 PLC
An acquisition vehicle acquiring businesses in creative, e-…
|
450 | JE | Financial and insurance activit… |
|
49 North Resources Inc.
A venture capital firm specializing in seed and early-stage…
|
FNR | CA | Financial and insurance activit… |
|
4Aim SICAF
An investment fund investing in listed or pre-listing SMEs,…
|
AIM | IT | Financial and insurance activit… |
|
786 Investment (Right)
Asset management and NBFC offering diverse investment produ…
|
786R | PK | Financial and insurance activit… |
RTW Biotech Opportunities Ltd via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/10552/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=10552 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=10552 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=10552 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 10552}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for RTW Biotech Opportunities Ltd (id: 10552)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.